Please login to view this media
- Talk
- 23/09/2021
- UK
Dual Mobility Cup Versus Conventional Total Hip Arthroplasty for Femoral Neck Fractures: An International Multi-Registry Study
Description
In this presentation, clinical lecturer James Masters discusses the complexities and considerations surrounding total hip replacement as a treatment for displaced intracapsular hip fractures, emphasizing the evolving guidelines influenced by recent studies, particularly the health trial. He highlights the significant contributors to dislocation rates, with evidence suggesting dislocation after this procedure can reach 20%. Masters introduces the dual-mobility construct as a potential solution to enhance stability and reduce dislocation rates, referencing a systematic review indicating its lower all-cause revision, dislocation, and mortality rates in respective cohorts.
He outlines the aim of his work to analyze multiple registries regarding dual mobility use versus conventional articulations to discern differences in the risks of all-cause revision and mortality. Masters details the participating registries from different countries, describing the methodologies employed, including Kaplan-Meier survival curves and Weibull proportional analysis, to forecast population distributions and control for various factors across 15,000 dual-mobility articulations and 97,000 conventional cases.
The presentation discusses demographic trends, showing a slightly older population for dual-mobility patients, and examines year-on-year usage trends revealing a significant uptake in registries like the Danish Hip Arthroplasty Registry. Insights include a noted trend towards lower all-cause revision rates for dual mobility and higher mortality rates over five years of follow-up, prompting a discussion on the paradox of registry report variations.
The session also includes an interactive segment with questions regarding the implications of the findings, with Masters pointing out potential biases in patient selection for dual mobility, suggesting the need for randomized trials to truly evaluate its effectiveness. This presentation contributes to the ongoing dialogue on improving outcomes for hip replacement procedures and highlights future research directions.